Competitive Tech to Host Private Engagement for Top Opinion Leaders at the ASCO 2014 Annual Meeting May 6, 2014
Guest Speakers to Discuss Calmare® Pain Device Therapy Treatment; Company Developed Medical Milestones and Advancements to be Disclosed
Conference: May 30 - June 3, 2015 | The McCormick Center, Chicago, IL | Booth 5072
Private Engagement: June 1, 2015 | Hyatt Regency McCormick Place, Chicago, IL
Fairfield, Conn. - (May 6, 2015) - Competitive Technologies, Inc., (CTTC) (CTI), the pain mitigation company, will host a private engagement for top opinion leaders in oncology at the Hyatt Regency McCormick Place on June 1, 2015 during the 50th Annual American Society of Clinical Oncology (ASCO) in Chicago, IL.
At the private engagement, there will be a morning panel discussion on the treatment of chemotherapy-induced peripheral neuropathy (CIPN) using Calmare Pain Device Therapy. The panel will consist of Dr. Thomas J. Smith from the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Medicine and Dr. Charles L. Loprinzi, Regis Professor of Breast Cancer Research, Division of Medical Oncology at the Mayo Clinic.
CTI will exhibit and feature their signature device, the Calmare Pain Device, at Booth 5072 at the McCormick Center during ASCO.
"ASCO 50th annual meeting is the perfect venue to introduce Calmare to the world's top opinion leaders," commented CTI President & CEO Conrad Mir. "We feel Calmare therapy may be the alternative therapy that patients, plagued with chronic pain, need in order to return to a pain-free lifestyle. As a medical device Company furthering such an innovative product, it is important that the medical community is made aware of this non-invasive approach that may revolutionize the way pain is managed."
